Review in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Shuang ZhangKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Ying LiuKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Heng JiangKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0009-0002-2080-0710
Jie GaoKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Quan YangKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0001-7816-8362
Kunhua WeiKey Laboratory of State Administration of Traditional Chinese Medicine for Production & Development of Cantonese Medicinal Materials, Guangzhou Comprehensive Experimental Station of National Industrial Technology System for Chinese Materia Medica, Guangdong Engineering Research Center of Good Agricultural Practice & Comprehensive Development for Cantonese Medicinal Materials, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Funding
Guangdong Provincial Science and Technology Program Project: Project for the Establishment of a Germplasm Resource Base and Repository for Southern Chinese Medicinal Herbs in Northern Guangdong 2024B1212060006Guangzhou Science and Technology Program Project: Research and Application of Key Technol-ogies for High-Quality Seedling Propagation and Cultivation of Bletilla striata 2025B03J0003
6 · The paper itself
Abstract
Bioreactor technology for medicinal plants provides a controllable platform for the conservation of rare and endangered resources, the production of high-value-added active ingredients, and green manufacturing of traditional Chinese medicine. Focusing on in vitro culture systems of medicinal plants, this article systematically reviews the application progress of stirred-tank, airlift, bubble column, wave-mixed, spray-type, temporary immersion, and photobioreactors in the culture of suspension cells, adventitious roots, hairy roots, shoots, and somatic embryos. Different from existing studies that mainly list reactor types, this review further provides a comprehensive analysis from the perspectives of physiological characteristics of the cultured objects, mass transfer and shear environment, medium and elicitor regulation, inoculation density, culture cycle, representative cases, and industrialization limitations. The results indicate that bioreactors can shorten production cycles, improve environmental controllability, and enhance product quality consistency; however, their large-scale application remains constrained by scale-up stability, metabolic fluctuations, downstream processing costs, GMP quality control, and commercial feasibility. Future research should shift from merely pursuing increased yield to integrated process development that is scalable, verifiable, low-cost, and quality-controllable.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bioreactor Technology for Medicinal Plant In Vitro Cultures: Systems, Applications, and Future Perspectives. · full record | OpenQuestion